The management of heart failure has evolved significantly over the years, but for some patients, conventional treatments are not enough. Heart failure and transplant cardiology focus on advanced therapeutic interventions, including the use of ventricular assist devices (VADs) and heart transplantation. When heart failure reaches an advanced stage, a transplant may be the only option for survival, but this requires careful evaluation of the patient’s overall health and compatibility with a donor heart. Post-transplant care is equally crucial, involving immunosuppressive drugs to prevent rejection, as well as ongoing monitoring for complications. Innovations in both transplant techniques and alternative therapies like gene therapy and stem cell treatments are paving the way for improved outcomes in these patients, offering hope for those with end-stage heart failure.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : The problem of sepsis in acute inflammation of lung tissue
Igor Klepikov, Tel Aviv University, Russian Federation
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation